Specialty Pharmacy

In this video from The Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo, Matthias Cheung, PhD, FCSHP, FASHP, from Advanced Rx Consulting, LLC, discusses the circumstances and factors that catalyzed the passage of current legislation and regulatory policies for orphan drugs, rare diseases, and ultra-rare diseases.

The newly released payer-directed resource from Avella details 10 of the most important issues payers should consider when selecting a specialty pharmacy.

Catamaran Corp, a leading provider of pharmacy benefit management (PBM) services and technology, today announced that its specialty brand, BriovaRx, has been awarded Specialty Pharmacy Accreditation from URAC.

A new drug to treat multiple sclerosis has the potential to drive spending increases in the specialty category.

BioPlus Specialty Pharmacy introduces the "2-Hour Patient Acceptance Guarantee" program for fast turn-around from patient referral to acceptance.

Prime Therapeutics' new studies, scheduled to be presented at AMCP, reveal that expected medical savings from the utilization of specialty drugs no longer offset the high cost of these therapies for the treatment of hepatitis C and rheumatoid arthritis.

Armada Health Care (Armada), the nation's largest specialty pharmacy channel management organization, is pleased to announce that it has been awarded Health Call Center, Health Web Site, and Health Content Provider accreditation from URAC.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, announced that it is launching a national advocacy initiative related to compounding that will be focused on pending federal and state legislation and regulation through agencies such as the FDA.

The court will decide whether "pay-to-delay" arrangements, in which the manufacturer of a branded medication pays another company to keep a generic version off the market, are legal.

The FDA today approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis (MS).

Specialty Pharmacy Times spoke to Glen Stettin, MD, senior vice president, clinical, research and new solutions, about the major findings of the report, the efficiency of patient engagement, and how the proportion of total drug spend for specialty medications will change in the coming years.

Adam J. Fein, PhD, of Pembroke Consulting and Drug Channels, appeared on FOX Business to discuss the recent partnership between Walgreens, Alliance Boots, and AmerisourceBergen.

The National Association of Specialty Pharmacy (NASP) announced Phil Hagerman, chief executive officer, Diplomat Specialty Pharmacy, has joined the NASP Board of Directors.

A study assessing HIV treatment interruption in 14 French subjects suggests that early initiation of antiretroviral therapy may be associated with sustained virological remission.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, announced it will be advocating against the impending cuts to Medicare reimbursement that are being driven by the sequestration process.

Walgreen Co and Alliance Boots GmbH, a leading international pharmacy-led health and beauty group, today announced that they have entered into an innovative long-term partnership with AmerisourceBergen, one of North America's largest pharmaceutical services companies.

Cardinal Health announced today that its pharmaceutical distribution contract with Walgreen Co (Walgreens), which is scheduled to expire at the end of August 2013, will not be renewed.

If new draft guidelines from the FDA take effect, drugs to treat Alzheimer's disease will only be required to demonstrate small improvements in patient cognition to qualify for approval.

Time is running out to nominate a deserving pharmacist, tech, or pharmacy student for the 4th annual Next-Generation Pharmacist awards program.

Biopharmaceutical companies have 907 biologic medicines and vaccines in development, according to a recent report from The Pharmaceutical Research and Manufacturers of America.

The global market for biosimilars is predicted to grow to $3.7 billion by 2015, according to a recent report by Grant Thornton. Will proposed legislation regarding the interchangeability of biosimilars thwart United States innovation and leave us far behind our European counterparts?

Improvements in adherence levels and outcomes for patients with hepatitis C were recently linked to the pharmacy channel through which the patients received their specialty medications.

We sat down with Kjel A. Johnson, PharmD, senior vice president, Strategy & Business Development, Magellan Pharmacy Solutions, to learn more about buy-and-bill practices, 340b drug pricing, and how site-of-care changes may affect the drugs covered under the medical benefit.

The Affordable Care Act will expand coverage and may open the door to elevated roles for pharmacists, former Health and Human Services Secretary Donna Shalala argued in a speech at the Miami Breast Cancer Conference.

A child born to a mother infected with HIV and aggressively treated with antiretroviral therapy starting shortly after birth appears to have been cured of HIV.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, today released a comprehensive Glossary of Specialty Pharmacy Terms.

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company servicing the needs of patients and physicians nationwide, announces the Company's new website is now live at www.diplomatpharmacy.com.

The average price of new drugs at launch is steadily increasing, making the case for their early management that much stronger, noted Christine Strahl of HealthPartners at the 2012 PBMI Drug Benefit Conference.

Health insurer Anthem pulled the plug on a policy in California that would require patients to get their specialty drugs through the mail.

Peter Wickersham, senior vice president of cost of care at Prime Therapeutics, revealed at this year's PBMI Drug Benefit Conference how to best structure benefit design and formulary to reduce specialty drug costs.